Tuesday, February 25, 2020

USFDA issues warning letter to Cipla for Goa manufacturing facility

USFDA issues warning letter to Cipla for Goa manufacturing facility The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations

from Moneycontrol Business News https://ift.tt/2wNZJKI

No comments:

Post a Comment

Zepto IPO, Swiggy QIP bad news for Eternal investors? Jefferies analysts decode

Jefferies has reiterated its Buy rating on Eternal with a target price of Rs 480, citing strong growth prospects, improving unit economics a...